Kobo Biotech quarterly results and financials

Kobo Biotech (BSE 531541)₹3.56−1.93%(9 Nov 2026 close)Commodity Chemicals

Key facts

In the Jun 2024 quarter (standalone), Kobo Biotech reported sales of ₹0 Cr and net profit of −₹1.32 Cr. For the year to Mar 2025, sales were ₹0 Cr and net profit −₹5.21 Cr.

Sales (Jun 2024): ₹0 Cr
Net profit (Jun 2024): −₹1.32 Cr
Sales (FY Mar 2025): ₹0 Cr
Net profit (FY Mar 2025): −₹5.21 Cr
EPS (Jun 2024): ₹−0.57
Borrowings (Mar 2025): ₹140 Cr

Company filings, standalone accounts; latest reported quarter Jun 2024

Kobo Biotech quarterly results

₹ crore unless stated; each column is a quarter.

Kobo Biotech Quarterly results
	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Sales	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Expenses	0.69	0.29	9.21	0.33	0.20	0.16	0.78	0.22	0.19	0.19	0.24	0.33
Operating Profit	−0.69	−0.29	−9.22	−0.33	−0.20	−0.16	−0.78	−0.22	−0.19	−0.19	−0.24	−0.33
Other Income	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.01
Interest	0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	1.02	1.03	1.17	1.14	0.88	1.02	0.99	1.00	1.01	1.02	1.00	1.00
Profit before tax	−1.85	−1.33	−10.39	−1.46	−1.09	−1.19	−1.78	−1.21	−1.21	−1.22	−1.25	−1.32
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net Profit	−1.85	−1.34	−10.39	−1.46	−1.09	−1.18	−1.78	−1.22	−1.21	−1.22	−1.25	−1.32
EPS (Rs)	−0.79	−0.58	−4.38	−0.63	−0.47	−0.51	−0.76	−0.53	−0.52	−0.53	−0.54	−0.57

Kobo Biotech profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Kobo Biotech Profit and loss
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	29.12	32.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Expenses	38.38	27.64	4.04	3.01	1.71	0.68	2.78	10.48	1.49	0.87	1.23	0.95
Operating Profit	−9.44	4.78	−4.04	−3.01	−1.71	−0.68	−2.78	−10.48	−1.49	−0.87	−1.23	−0.95
OPM %	−32.6%	14.7%	—	—	—	—	—	—	—	—	—	—
Other Income	2.59	0.41	5.99	0.03	−2.14	0.02	0.03	0.01	0.01	0.01	0.07	0.01
Interest	15.66	14.40	14.44	14.53	14.47	14.50	10.87	0.14	0.00	0.00	0.00	0.00
Depreciation	7.75	7.28	6.75	6.42	6.13	5.85	5.62	4.59	4.06	4.06	4.05	4.03
Profit before tax	−30.16	−16.39	−19.15	−23.83	−24.36	−20.94	−19.17	−15.18	−5.53	−4.91	−5.21	−5.00
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—
Exceptional items	2.53	0.00	0.00	0.00	−2.17	0.00	0.00	0.00	0.00	0.00	0.00	—
Net Profit	−30.18	−16.41	−19.20	−23.85	−24.41	−20.95	−19.18	−15.19	−5.54	−4.92	−5.21	−5.00
EPS (Rs)	−13.48	−6.96	−8.10	−10.07	−10.29	−8.84	−8.09	−6.41	−2.34	−2.08	−2.21	−2.16
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Kobo Biotech balance sheet

₹ crore, at each year end.

Kobo Biotech Balance sheet
	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	22.45	22.44	23.65	23.77	23.77	23.75	23.74	23.75	23.76	23.76	23.75	23.76
Reserves	22.06	−8.84	−17.31	−42.42	−66.39	−90.81	−112	−131	−146	−152	−157	−162
Borrowings	137	142	153	207	222	236	250	260	141	140	139	140
Other Liabilities	97.62	95.81	101	63.31	66.65	70.37	73.64	77.32	61.19	63.78	64.93	70.17
Total Liabilities	279	252	260	252	246	239	236	230	79.19	75.29	71.36	71.51
Fixed Assets	104	95.28	87.92	81.22	74.69	68.56	62.62	57.02	41.77	37.69	33.58	29.52
CWIP	2.24	2.24	2.24	2.24	2.24	2.24	2.24	2.24	0.00	0.00	0.00	0.00
Investments	12.18	12.20	12.21	12.20	12.20	12.20	12.20	12.20	0.00	0.00	0.00	0.00
Other Assets	161	142	158	156	156	156	159	159	37.42	37.60	37.78	41.99
Inventories	76.19	70.21	55.63	55.64	55.60	53.44	53.40	53.40	18.09	18.09	18.09	18.08
Trade receivables	65.46	56.26	89.98	88.96	88.99	90.83	93.56	92.66	11.83	11.99	11.99	12.04
Cash & equivalents	1.43	0.23	0.60	0.14	0.12	0.14	0.14	1.57	0.14	0.14	0.17	4.37
Total Assets	279	252	260	252	246	239	236	230	79.19	75.29	71.36	71.51

Kobo Biotech cash flow

₹ crore, for each year.

Kobo Biotech Cash flow
	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from operating activity	11.04	19.35	5.63	32.36	31.52	20.97	14.49	2.52	93.96	0.88	0.21	4.19
Cash from investing activity	−4.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	25.16	0.00	0.00	0.00
Cash from financing activity	−6.98	−20.44	−5.25	−32.69	−31.37	−20.90	−14.42	−1.07	−120	−0.86	−0.14	0.00
Net cash flow	−0.70	−1.19	0.36	−0.47	0.00	0.00	0.00	1.44	−1.44	0.00	0.06	4.19
Capex	4.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Free cash flow	6.33	19.35	5.63	32.38	31.52	20.98	14.51	2.52	107	0.88	0.21	4.19
CFO / OP %	−260.0%	−203.9%	117.0%	−798.0%	−1,042.0%	−1,218.0%	−2,099.0%	−90.0%	−891.9%	−57.9%	−23.0%	−337.0%

Kobo Biotech ratios

Working-capital days and returns, by year.

Kobo Biotech Ratios
	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor days	419	706	1,006	—	—	—	—	—	—	—	—	—
Inventory days	585	896	1,039	—	—	—	—	—	—	—	—	—
Days payable	405	660	1,093	—	—	—	—	—	—	—	—	—
Cash conversion cycle	599	943	953	—	—	—	—	—	—	—	—	—
Working capital days	27	−277	−251	—	—	—	—	—	—	—	—	—
ROCE %	−7.1%	−10.1%	−1.3%	−2.8%	−5.1%	−4.5%	−3.9%	−5.3%	−17.6%	−36.7%	−52.8%	−125.5%

Kobo Biotech: frequently asked questions

What are the latest quarterly results of Kobo Biotech?

For the Jun 2024 quarter, Kobo Biotech reported sales of ₹0 Cr and net profit of −₹1.32 Cr.

What is the annual revenue of Kobo Biotech?

Kobo Biotech's sales for the year to Mar 2025 were ₹0 Cr; over the last twelve months they were ₹0 Cr.

What is the net profit of Kobo Biotech?

Net profit for the year to Mar 2025 was −₹5.21 Cr, and −₹5 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−2.16.

How much debt does Kobo Biotech have?

Kobo Biotech reported borrowings of ₹140 Cr at Mar 2025, against cash and equivalents of ₹4.37 Cr.

What is the free cash flow of Kobo Biotech?

Cash from operations was ₹4.19 Cr in the year to Mar 2025; after capital spending, free cash flow was ₹4.19 Cr.

Loading…